2,893 matches for your search in the start-up spotlight
rss
BioVersys AG is a privately-owned clinical stage Swiss pharmaceutical company focusing on research and development of small molecules acting on novel bacterial targets with applications in antimicrobial resistance (AMR) and targeted microbiome modulation. With the company's award-winning TRIC ...
akvola Technologies is a water technology company specialized in the treatment of hard-to-treat industrial wastewater with a focus in the removal of oil (free, dispersed and emulsified) and suspended solids. akvola Technologies sells custom solutions equipped with akvoFloat™ – a proprietary ...
Cysal GmbH uses an internationally patented, biotechnological process to produce arginineaspartate and lysine-aspartate dipeptides on an industrial scale. The biotechnology company uses these dipeptides, a combination of two amino acids, as the base material for the ...
The core competence of Li.plus GmbH, which was founded in October 2016, is the commercial exploitation of a rapid battery test procedure developed as part of university research and the associated know-how. In addition, the company has an extensive base of detailed battery diagnostic data and ...
A new star is born, a new light in the sky of bioanalytics: Accelerō® Bioanalytics. Inspired by expert knowledge. Old hands at work. We are committed to become a preferred partner in bioanalytical services for the nucleic acids biotechnology and pharmaceutical industry. Accelerō® Bioanalytics ...
Computomics is a spin-off of the University of Tübingen and the Max Planck Institute for Developmental Biology. Computomics was founded in 2012 when it became apparent that crop companies are interested in the cutting-edge bioinformatics analyses enabled by a breakthrough in DNA sequencing ...
We are a company focused on the research, development and manufacturing of innovative diagnostic tests to determine risk factors of dementia-related diseases. We have set ourselves the goal of being able to diagnose the various forms of dementia earlier and more reliably through the innovative ...
t2cure GmbH is a biopharmaceutical company engaged in the field of stem cell-based regenerative medicine. It develops and markets autologous bone marrow-derived progenitor cells as regenerative therapeutics for cardiovascular disease including ischemic heart disease (acute myocardial infarction ...
